FDA approves anti-body rich plasma for COVID-19

[drusso]

...old fashioned regen med treatment...

FDA will allow doctors to treat critically ill coronavirus patients with blood from survivors

Experts say the treatment might be the best hope for some patients until more sophisticated drugs are developed.

www.nbcnews.com

The treatment, known as convalescent plasma, dates back centuries and was used during the flu pandemic of 1918, in an era before modern vaccines and antiviral drugs. Some experts have argued that it might be the best hope for combating the coronavirus until more sophisticated therapies can be developed, which could take several months.

---

Members don't see this ad.

 

[deleted131481]

 

[Ligament]

Platelet rich plasma cures COVID?

 

[hyperalgesia]

Is a bone marrow transplant for leukemia now considered "regenerative medicine"?

 

[drusso]

Is a bone marrow transplant for leukemia now considered "regenerative medicine"?

Well, if you really think about it...yes. Ditto for epidural blood batches. Before there was even a conception of regenerative medicine it already existed.

 

[Doctodd]

Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma

This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral treatment who were given human plasma with SARS-CoV-2 antibodies obtained from previously infected and recovered patients.

jamanetwork.com

Key Points
Question Could administration of convalescent plasma transfusion be beneficial in the treatment of critically ill patients with coronavirus disease 2019 (COVID-19)?

Findings In this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status.

Meaning These preliminary findings raise the possibility that convalescent plasma transfusion may be helpful in the treatment of critically ill patients with COVID-19 and ARDS, but this approach requires evaluation in randomized clinical trials.